Investigating the effect of 12 weeks of HIFT and Ginkgo biloba consumption on serum levels of inflammatory indicators and antioxidant defense

The effect of 12 weeks of high-intensity functional training (HIFT) and Ginkgo biloba consumption on serum levels of inflammatory indicators, antioxidant defense and physical performance in Yazd firefighters.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230919059465N1

Enrollment

Registered

2024-02-17

Start date

2024-02-20

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory status and antioxidant defense. --

Interventions

Intervention 1: The first intervention: consists of performing high-intensity functional training (HIFT). The subjects of this intervention (12 people) perform HIFT exercises for 12 weeks and 4 sessio

Eligibility

Sex/Gender

Male

Age

1382 Years to 1352 Years

Inclusion criteria

Inclusion criteria: All firefighters who are in the operational line, have more than 3 years of work experience, age range of 25 to 50 years, not suffering from specific physiological and metabolic diseases, not taking special dietary and sports supplements.

Exclusion criteria

Exclusion criteria: Work experience of less than 3 years, age less than 25 years and more than 50 years, suffering from a disabling disease from participating in training, taking special dietary and sports supplements

Design outcomes

Primary

Measure	Time frame
Lipocalin-2. Timepoint: Two stages: before the start of the study and after the end of 12 weeks of interference. Method of measurement: Valid and standard lipocalin-2 laboratory kit.;Interleukin-8 (IL-8). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard IL-8 laboratory kit.;Interleukin-1beta (IL-1ß). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard IL-1ß laboratory kit.;Superoxide desmutase (SOD). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard SOD laboratory kit.;Catalase (CAT). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard CAT laboratory kit.	—

Measure

Time frame

Lipocalin-2. Timepoint: Two stages: before the start of the study and after the end of 12 weeks of interference. Method of measurement: Valid and standard lipocalin-2 laboratory kit.;Interleukin-8 (IL-8). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard IL-8 laboratory kit.;Interleukin-1beta (IL-1ß). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard IL-1ß laboratory kit.;Superoxide desmutase (SOD). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard SOD laboratory kit.;Catalase (CAT). Timepoint: Two stages: before the start of the study and after the end of 12 weeks of intervention. Method of measurement: Valid and standard CAT laboratory kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Sedaghat

Islamic Azad University

hsedaghat9194@gmail.com+98 35 3623 5396

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026